TCE-RRMM

Clinical trial pipeline · Data from ClinicalTrials.gov

See which TCE-RRMM trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT07280013

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myelom…

The main purpose of the study is to understand the safety and tolerability of cemsidomide when given along with elranatamab in subjects with relapsed or refract…

United States60 participantsStarted 2026-02-06

Treatment: Cemsidomide, Elranatamab

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07320326

ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab

This registry study will provide valuable evidence to assess and validate its effectiveness in the Chinese MM population, refine clinical application strategies…

China159 participantsStarted 2025-12-30

Treatment: Elranatamab

CompletedNot Applicable

NCT05673967

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Primary Objective: 1\. To describe the distribution of treatment regimens and objective response rate (ORR) in a Benchmark Cohort of real-world patients with r…

United States62 participantsStarted 2023-01-09

Treatment: Non-Interventional